| Chronic Cough and Small Fiber Neuropathy (NCT03787511) | University Hospital, Toulouse | 2022-06-14 |
| A Clinical Trial to Evaluate the Safety and Efficacy in Subjects With Chronic Cough (NCT05392192) | Aldeyra Therapeutics, Inc. | 2022-04-07 |
| A Trial of HRS-2261 in Healthy Subjects After Single and Multiple Oral Administration (NCT05274516) | Guangdong Hengrui Pharmaceutical Co., Ltd | 2022-03-28 |
| Prospective Study on the Evaluation, Patient Reported Outcomes and Effectiveness of Treatment for Chronic Cough (NCT04758351) | McMaster University | 2021-12-14 |
| Mepolizumab for the Treatment of Chronic Cough With Eosinophilic Airways Diseases (NCT04765722) | McMaster University | 2021-12-14 |
| A Study of Efficacy and Safety of AX-8 in Chronic Cough (NCT04866563) | Axalbion SA | 2021-08-11 |
| Study of AffloVest in At-Risk Respiratory Patients During COVID-19 Pandemic (NCT04654481) | Icahn School of Medicine at Mount Sinai | 2021-07-20 |
| A Multi-center Study to Determine the Prevalence and Influence of Pertussis on Subacute Cough in Shenzhen (NCT04694963) | Shenzhen People's Hospital | 2021-01-01 |
| Efficacy and Safety of Gefapixant (MK-7264) in Women With Chronic Cough and Stress Urinary Incontinence (MK-7264-042) (NCT04193176) | Merck Sharp & Dohme LLC | 2020-05-10 |
| Evaluation of S-600918 in Adults With Refractory Chronic Cough (NCT04110054) | Shionogi | 2020-02-13 |
| A Study of Gefapixant (MK-7264) in Adult Participants With Chronic Cough (MK-7264-030)-China Extension (NCT04525885) | Merck Sharp & Dohme LLC | 2019-05-17 |
| A Dose Escalation Study of Bradanicline in Refractory Chronic Cough (NCT03622216) | Attenua, Inc. | 2018-11-05 |
| A Study of Gefapixant (MK-7264) in Japanese Adult Participants With Refractory or Unexplained Chronic Cough (MK-7264-038) (NCT03696108) | Merck Sharp & Dohme LLC | 2018-10-31 |
| ATP and Capsaicin Cough Provocation Test in Chronic Cough and Bronchiectasis (NCT03638063) | Guangzhou Institute of Respiratory Disease | 2018-10-29 |
| Cough in Eastern and Central Finland (NCT03639727) | Kuopio University Hospital | 2018-09-01 |
| Study of Gefapixant (MK-7264) in Adult Japanese Participants With Unexplained or Refractory Chronic Cough (MK-7264-033) (NCT03482713) | Merck Sharp & Dohme LLC | 2018-03-16 |
| A Study of Gefapixant (MK-7264) in Adult Participants With Chronic Cough (MK-7264-027) (NCT03449134) | Merck Sharp & Dohme LLC | 2018-03-14 |
| Sham CPAP vs. Straight CPAP for Chronic Cough (NCT03172130) | Krishna M. Sundar | 2014-10-13 |
| French Linguistic and Metric Validations of Parent-proxy QOL Chronic Cough Specific Questionnaire (PC-QOL) (NCT01865422) | Assistance Publique Hopitaux De Marseille | 2013-05-01 |
| The Use of Capsaicin Challenge for Diagnosis, Monitoring and Follow-up of Chronic Cough. (NCT01807832) | Tel-Aviv Sourasky Medical Center | 2013-03-01 |
| Prospective, Comparative, Randomized, Controlled Trial on the Efficacy of the Treatment of Gastroesophageal Reflux Infant With Magnesium Alginate (NCT01858584) | Federico II University | 2013-02-01 |
| Cough Reflex Sensitivity and Bronchial Hyper-responsiveness (NCT01777867) | Mayo Clinic | 2012-12-01 |
| A Study to Assess the Efficacy of Gefapixant (MK-7264/AF-219), in Participants With Chronic Cough (MK-7264-006) (NCT01432730) | Afferent Pharmaceuticals, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2011-09-22 |
| Lidocaine: Effect of Lidocaine in Chronic Cough (NCT01252225) | Manchester University NHS Foundation Trust | 2011-02-01 |
| Novel Endpoints in Cough Challenge Testing (NCT01566968) | Manchester University NHS Foundation Trust | 2011-01-01 |
| Cough Responses to Tussive Agents in Health and Disease (NCT01297790) | Manchester University NHS Foundation Trust | 2009-11-01 |
| Neurophysiology and Pharmacology of Cough Reflex Hypersensitivity (NCT00858624) | Jacky Smith | 2008-02-01 |